ABVC BioPharma, Inc. Announces Planned Spin-Off of BioKey , Inc. Through Dividend Distribution of BioKey Shares to ABVC ...
ABVC BioPharma, Inc. (NASDAQ: ABVC) ("ABVC" or the "Company"), a clinical-stage biopharmaceutical company focused on botanical-derived therapeutics and commercial ingredient platforms, today announced the planned spin-off of BioKey ( …